Quantcast

Generic-drug industry tells 4th Circuit to let price-gouging ruling stand

Maryland seeks 4th Circuit's reversal of decision striking down law

Generic-drug makers and distributors have urged the full 4th U.S. Circuit Court of Appeals to let stand a three-judge panel’s decision last month striking down as unconstitutional Maryland’s law aimed at preventing unwarranted price increases by their industry.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *

*